Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Report of the Workshop held in Scottsdale, Arizona, USA, on February 23-25, 1987

Cancer Genetics and Cytogenetics

Volumn 32, Issue 1, 1988, Pages 1-10

  Bennett, John M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW BIOPSY; CLASSIFICATION; CYTOCHEMISTRY; CYTOGENETICS; HISTOCHEMISTRY; HISTOLOGY; HUMAN; MYELODYSPLASIA; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; AGED; BONE MARROW; CHROMOSOME ABERRATIONS; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGE; MYELODYSPLASTIC SYNDROMES; PROGNOSIS;

EID: 0023888449     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(88)90303-2     Document Type: Article

References (36)

1. Morphologic immunologic and cytogenic (MIC) working classification of acute lymphoblastic leukemias
2. Morphologic immunologic and cytogenetic (MIC) working classification of acute myeloid leukemias
3. Proposals for the classification of the myelodysplastic syndromes
4. Therapy related acute myeloid leukemia and myelodysplastic syndromes: A clinical and morphologic study of 65 cases
5. Clinical and cytogenetic correlations in 63 patients with therapy related myelodysplastic syndromes and acute non lymphocytic leukemias: Further incidence for characteristic abnormalities of chromosome nos. 5 and 7
6. Natural history of smouldering leukemia
7. Modifications in the classification of primary myelodysplastic syndrome The addition of a scoring system
8. Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients
9. Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation A study of 118 cases
10. Bone marrow histology in myelodysplastic syndromes and comparison with bone marrow smears
11. Chronic myelomonocytic leukemia according to the FAB classification: Analysis of 35 cases
12. Chronic myelodysplastic syndrome: Short survival with or without evolution to acute leukemia
13. Myelodysplastic syndromes: A scoring system with prognostic significance
14. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases
15. Myelodysplastic syndromes: A study of 101 cases according to the FAB classification
16. Utility of the FAB classification for myelodysplastic syndromes investigation of prognostic factors in 237 cases
17. Preleukemic states in children
18. Childhood monosomy 7 syndrome: Clinical and in vitro studies
19. Recommended methods for cytological procedures in haematology
20. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7)
21. Esterase cytochemistry in primary myelodysplastic syndromes and megaloblastic anaemia: Demonstration of abnormal staining patterns associated with dysmyelopoiesis
22. Primary acquired sideroblastic anaemias
23. Bone marrow histology in myelodysplastic syndromes
24. Bone marrow histology in myelodysplastic syndromes. II Prognostic value of abnormal localization of immature precursors in MDS
25. Therapy induced myelodysplasia and secondary leukaemia
26. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes
27. Fourth International Workshop on Chromosomes in Leukemia
28. Karyotypic evolution in patients with myelodysplastic syndromes
29. Deletion of chromosome band 13q14: A primary event in preleukemia and leukemia
30. Chromosome studies in preleukemic states. V Prognostic significance of single versus multiple abnormalities
31. Amplified dihydrofolate reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes
32. Homogenously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma
33. The 5q - anomaly
34. Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome
35. Childhood bone marrow monosomy 7 syndrome: A familial disorder?
36. 11q - chromosome is associated with abnormal iron stores in myelodysplastic syndromes